| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.599 | 0.019 | 0.599 | Aldehyde oxidase inhibitor | |||
| 0.581 | 0.003 | 0.581 | Interleukin 2 antagonist | 0.196 0.008 CID_154699805 | ||
| 0.594 | 0.019 | 0.725 | Cholesterol antagonist | 0.725 0.006 CID_154699805 | CID_154699805 | |
| 0.51 | 0.019 | 0.51 | Interleukin antagonist | 0.301 0.048 CID_154699805 | ||
| 0.54 | 0.072 | 0.8 | Antiinflammatory | 0.8 0.015 CID_154699805 | CID_154699805 | |
| 0.481 | 0.021 | 0.481 | Lipoxygenase inhibitor | |||
| 0.468 | 0.042 | 0.546 | Immunosuppressant | 0.546 0.021 CID_154699805 | CID_154699805 | |
| 0.409 | 0.024 | 0.477 | Hypolipemic | 0.477 0.014 CID_154699805 | CID_154699805 | |
| 0.407 | 0.057 | 0.407 | Toll-Like receptor 7 agonist | |||
| 0.426 | 0.077 | 0.641 | Cyclophilin D inhibitor | 0.641 0.021 CID_154699805 | CID_154699805 | |
| 0.352 | 0.009 | 0.352 | Amyloid beta precursor protein antagonist | |||
| 0.401 | 0.06 | 0.401 | Toll-Like receptor agonist | |||
| 0.341 | 0.021 | 0.531 | Non-steroidal antiinflammatory agent | 0.531 0.005 CID_154699805 | CID_154699805 | |
| 0.311 | 0.005 | 0.311 | Prostaglandin antagonist | |||
| 0.311 | 0.007 | 0.311 | Ferrochelatase inhibitor | |||
| 0.287 | 0.019 | 0.287 | Cyclooxygenase inhibitor | 0.162 0.061 CID_154699805 | ||
| 0.268 | 0.004 | 0.268 | CYP2A6 inhibitor | |||
| 0.267 | 0.004 | 0.267 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.341 | 0.092 | 0.341 | Antiobesity | |||
| 0.351 | 0.115 | 0.351 | 5 Hydroxytryptamine release inhibitor | 0.305 0.159 CID_154699805 | ||
| 0.284 | 0.052 | 0.284 | Pyruvate kinase inhibitor | |||
| 0.217 | 0.006 | 0.217 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.215 | 0.005 | 0.215 | Prostaglandin EP2 antagonist | 0.118 0.015 CID_154699805 | ||
| 0.227 | 0.026 | 0.227 | Cyclooxygenase 1 inhibitor | 0.144 0.06 CID_154699805 | ||
| 0.205 | 0.009 | 0.205 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.209 | 0.026 | 0.209 | Catenin beta inhibitor | |||
| 0.207 | 0.027 | 0.382 | Cell wall synthesis inhibitor | 0.382 0.007 CID_154699805 | CID_154699805 | |
| 0.209 | 0.031 | 0.257 | Alpha-N-acetylglucosaminidase inhibitor | 0.257 0.022 CID_154699805 | CID_154699805 | |
| 0.202 | 0.03 | 0.202 | Cyclooxygenase 2 inhibitor | 0.112 0.089 CID_154699805 | ||
| 0.296 | 0.126 | 0.397 | Histamine release inhibitor | 0.397 0.077 CID_154699805 | CID_154699805 | |
| 0.171 | 0.005 | 0.171 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.231 | 0.07 | 0.231 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.151 | 0.009 | 0.151 | Alpha 2d adrenoreceptor antagonist | 0.1 0.048 CID_154699805 | ||
| 0.156 | 0.016 | 0.171 | CC chemokine 6 receptor antagonist | 0.171 0.007 CID_154699805 | CID_154699805 | |
| 0.208 | 0.07 | 0.208 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.243 | 0.107 | 0.243 | Hypoxia-inducible factor 1 alpha inhibitor | 0.239 0.111 CID_154699805 | ||
| 0.153 | 0.026 | 0.153 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.142 0.029 CID_154699805 | ||
| 0.131 | 0.004 | 0.131 | Squalene epoxidase inhibitor | 0.117 0.004 CID_154699805 | ||
| 0.148 | 0.022 | 0.148 | DOPA decarboxylase inhibitor | |||
| 0.129 | 0.008 | 0.129 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.183 | 0.064 | 0.183 | Succinate dehydrogenase inhibitor | |||
| 0.176 | 0.058 | 0.176 | Arachidonic acid antagonist | |||
| 0.187 | 0.07 | 0.187 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.127 | 0.011 | 0.127 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.147 | 0.034 | 0.147 | Mucolytic | 0.127 0.048 CID_154699805 | ||
| 0.128 | 0.016 | 0.128 | Beta tubulin antagonist | |||
| 0.129 | 0.018 | 0.129 | Peroxisome proliferator-activated receptor gamma agonist | |||
| 0.147 | 0.039 | 0.226 | Microtubule formation inhibitor | 0.226 0.015 CID_154699805 | CID_154699805 | |
| 0.191 | 0.083 | 0.191 | Insulin sensitizer | |||
| 0.13 | 0.023 | 0.13 | Estrogen receptor beta antagonist | |||
| 0.111 | 0.005 | 0.111 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.116 | 0.01 | 0.116 | NMDA receptor glycine site agonist | |||
| 0.24 | 0.134 | 0.558 | Antithrombotic | 0.558 0.021 CID_154699805 | CID_154699805 | |
| 0.126 | 0.022 | 0.126 | Ornithine decarboxylase inhibitor | |||
| 0.108 | 0.005 | 0.108 | Retinoid X alpha receptor agonist | |||
| 0.148 | 0.048 | 0.157 | Ca2+-transporting ATPase inhibitor | 0.157 0.029 CID_154699805 | CID_154699805 | |
| 0.157 | 0.058 | 0.174 | Mannose-6-phosphate isomerase inhibitor | 0.174 0.046 CID_154699805 | CID_154699805 | |
| 0.213 | 0.114 | 0.213 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.171 | 0.073 | 0.171 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.154 | 0.056 | 0.154 | Adenylate cyclase stimulant | |||
| 0.217 | 0.121 | 0.217 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.206 | 0.111 | 0.206 | Superoxide dismutase inhibitor | |||
| 0.136 | 0.041 | 0.152 | Photosensitizer | 0.152 0.03 CID_154699805 | CID_154699805 | |
| 0.132 | 0.036 | 0.132 | Estrogen antagonist | 0.106 0.083 CID_154699805 | ||
| 0.098 | 0.005 | 0.098 | Prostaglandin D2 antagonist | |||
| 0.109 | 0.016 | 0.109 | NMDA receptor agonist | |||
| 0.102 | 0.01 | 0.102 | Glutamate (mGluR6) antagonist | |||
| 0.146 | 0.056 | 0.146 | Heat shock protein 70 antagonist | 0.134 0.1 CID_154699805 | ||
| 0.1 | 0.014 | 0.1 | Prostaglandin E2 antagonist | |||
| 0.115 | 0.034 | 0.115 | ABCA1 expression enhancer | |||
| 0.154 | 0.073 | 0.266 | Interferon gamma antagonist | 0.266 0.025 CID_154699805 | CID_154699805 | |
| 0.087 | 0.006 | 0.087 | Retinoid X receptor agonist | |||
| 0.102 | 0.024 | 0.102 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.091 | 0.015 | 0.091 | Thromboxane antagonist | |||
| 0.08 | 0.005 | 0.08 | Peroxisome proliferator-activated receptor alpha antagonist | |||
| 0.135 | 0.062 | 0.135 | Antibacterial (Helicobacter pylori) | 0.125 0.074 CID_154699805 | ||
| 0.078 | 0.005 | 0.078 | Prostaglandin EP4 antagonist | |||
| 0.079 | 0.006 | 0.079 | Peroxisome proliferator-activated receptor delta antagonist | |||
| 0.078 | 0.007 | 0.078 | Prostaglandin agonist | |||
| 0.079 | 0.008 | 0.079 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.083 | 0.013 | 0.083 | Thromboxane A2 antagonist | |||
| 0.087 | 0.017 | 0.087 | Transcription factor AP-1 inhibitor | 0.073 0.028 CID_154699805 | ||
| 0.22 | 0.154 | 0.223 | Vasodilator, peripheral | 0.223 0.151 CID_154699805 | CID_154699805 | |
| 0.075 | 0.009 | 0.075 | Urate transporter 1 inhibitor | |||
| 0.126 | 0.06 | 0.126 | Cholesterol synthesis inhibitor | |||
| 0.074 | 0.009 | 0.074 | TRPM8 blocker | |||
| 0.157 | 0.093 | 0.157 | Phospholipase C inhibitor | |||
| 0.07 | 0.007 | 0.07 | Endothelin receptor antagonist | |||
| 0.134 | 0.071 | 0.134 | Interleukin 1 antagonist | |||
| 0.237 | 0.175 | 0.237 | 15-Lipoxygenase inhibitor | |||
| 0.066 | 0.004 | 0.066 | Retinoid X receptor antagonist | |||
| 0.077 | 0.016 | 0.077 | Plasminogen activator inhibitor antagonist | |||
| 0.141 | 0.082 | 0.297 | NOS3 expression enhancer | 0.297 0.018 CID_154699805 | CID_154699805 | |
| 0.084 | 0.024 | 0.084 | Protein kinase C iota inhibitor | |||
| 0.063 | 0.005 | 0.063 | Leukotriene B4 receptor 1 antagonist | 0.026 0.021 CID_154699805 | ||
| 0.062 | 0.005 | 0.062 | Prostaglandin E2 agonist | |||
| 0.103 | 0.045 | 0.135 | Triose-phosphate isomerase inhibitor | 0.135 0.025 CID_154699805 | CID_154699805 | |
| 0.194 | 0.137 | 0.194 | Streptokinase A inhibitor | |||
| 0.219 | 0.163 | 0.219 | Sodium/bile acid cotransporter inhibitor | |||
| 0.066 | 0.009 | 0.066 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.127 | 0.072 | 0.127 | Vanilloid 1 agonist | 0.114 0.103 CID_154699805 | ||
| 0.128 | 0.073 | 0.128 | Tubulin antagonist | |||
| 0.111 | 0.057 | 0.225 | Expectorant | 0.225 0.016 CID_154699805 | CID_154699805 | |
| 0.067 | 0.013 | 0.067 | Progesterone antagonist | |||
| 0.093 | 0.039 | 0.093 | Porphobilinogen synthase inhibitor | |||
| 0.135 | 0.082 | 0.135 | Protein kinase (CK1) gamma 1 inhibitor | |||
| 0.106 | 0.054 | 0.106 | Anabolic | |||
| 0.056 | 0.004 | 0.056 | Retinoid X alpha receptor antagonist | |||
| 0.071 | 0.019 | 0.071 | Leukotriene B4 antagonist | 0.057 0.031 CID_154699805 | ||
| 0.1 | 0.049 | 0.1 | Bile acid receptor antagonist | |||
| 0.055 | 0.004 | 0.055 | Leukotriene B4 receptor 2 antagonist | 0.024 0.013 CID_154699805 | ||
| 0.173 | 0.123 | 0.24 | Platelet antagonist | 0.24 0.077 CID_154699805 | CID_154699805 | |
| 0.067 | 0.016 | 0.067 | Estrogen receptor beta agonist | 0.053 0.019 CID_154699805 | ||
| 0.117 | 0.067 | 0.117 | Protein kinase (CK1) gamma 2 inhibitor | |||
| 0.055 | 0.005 | 0.055 | Integrin alpha1beta1 antagonist | |||
| 0.14 | 0.091 | 0.197 | Hexokinase inhibitor | 0.197 0.037 CID_154699805 | CID_154699805 | |
| 0.081 | 0.031 | 0.081 | Leukotriene antagonist | |||
| 0.09 | 0.041 | 0.09 | Estrogen-related receptor beta agonist | |||
| 0.106 | 0.058 | 0.106 | Adenylate kinase inhibitor | |||
| 0.071 | 0.023 | 0.071 | Alpha tubulin antagonist | |||
| 0.149 | 0.104 | 0.149 | Neurotensin receptor agonist | |||
| 0.073 | 0.031 | 0.073 | MDM2 inhibitor | |||
| 0.118 | 0.076 | 0.21 | DNA repair enzyme inhibitor | 0.21 0.008 CID_154699805 | CID_154699805 | |
| 0.072 | 0.031 | 0.072 | Biliverdin reductase inhibitor | |||
| 0.084 | 0.042 | 0.084 | Estrogen receptor alpha antagonist | |||
| 0.047 | 0.006 | 0.047 | Retinoid X gamma receptor agonist | |||
| 0.162 | 0.121 | 0.162 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.131 | 0.09 | 0.131 | Cytidine deaminase inhibitor | |||
| 0.08 | 0.04 | 0.08 | Vanilloid 4 agonist | |||
| 0.089 | 0.05 | 0.089 | Vanilloid agonist | |||
| 0.041 | 0.003 | 0.041 | Retinoid X beta receptor antagonist | |||
| 0.15 | 0.113 | 0.158 | Anesthetic general | 0.158 0.105 CID_154699805 | CID_154699805 | |
| 0.137 | 0.101 | 0.172 | Melanin inhibitor | 0.172 0.057 CID_154699805 | CID_154699805 | |
| 0.097 | 0.061 | 0.097 | Electrolyte absorption antagonist | |||
| 0.053 | 0.017 | 0.053 | Estrogen receptor alpha agonist | |||
| 0.231 | 0.195 | 0.588 | Antibacterial | 0.588 0.021 CID_154699805 | CID_154699805 | |
| 0.041 | 0.006 | 0.041 | Retinoid X beta receptor agonist | |||
| 0.056 | 0.021 | 0.056 | Dopamine beta hydroxylase inhibitor | |||
| 0.14 | 0.106 | 0.14 | Antipruritic | |||
| 0.06 | 0.027 | 0.099 | Adenine nucleotide translocase inhibitor | 0.099 0.005 CID_154699805 | CID_154699805 | |
| 0.058 | 0.025 | 0.094 | Glucose-6-phosphate translocase inhibitor | 0.094 0.007 CID_154699805 | CID_154699805 | |
| 0.099 | 0.067 | 0.099 | GABA C receptor agonist | |||
| 0.122 | 0.09 | 0.161 | Protein kinase stimulant | 0.161 0.061 CID_154699805 | CID_154699805 | |
| 0.036 | 0.005 | 0.036 | Retinoic acid alpha receptor antagonist | |||
| 0.097 | 0.066 | 0.097 | 5-Lipoxygenase inhibitor | |||
| 0.046 | 0.016 | 0.046 | MAP3K5 inhibitor | |||
| 0.053 | 0.023 | 0.053 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.036 | 0.006 | 0.036 | Retinoid X gamma receptor antagonist | |||
| 0.059 | 0.03 | 0.059 | DNA helicase inhibitor | |||
| 0.041 | 0.012 | 0.041 | Diacylglycerol O-acyltransferase 1 inhibitor | |||
| 0.038 | 0.009 | 0.038 | Prostaglandin EP2 agonist | |||
| 0.046 | 0.019 | 0.046 | Kainate receptor agonist | |||
| 0.036 | 0.009 | 0.036 | Endothelin A receptor antagonist | |||
| 0.049 | 0.023 | 0.049 | Liver X receptor agonist | |||
| 0.031 | 0.005 | 0.031 | Retinoic acid receptor antagonist | 0.017 0.015 CID_154699805 | ||
| 0.057 | 0.032 | 0.057 | Thromboxane synthase inhibitor | |||
| 0.032 | 0.007 | 0.032 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.129 | 0.104 | 0.129 | Pregnane X receptor agonist | |||
| 0.092 | 0.068 | 0.139 | Xanthine oxidase inhibitor | 0.139 0.039 CID_154699805 | CID_154699805 | |
| 0.056 | 0.032 | 0.056 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.056 | 0.032 | 0.062 | Estrogen agonist | 0.062 0.029 CID_154699805 | CID_154699805 | |
| 0.054 | 0.031 | 0.054 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.032 | 0.009 | 0.032 | Retinoic acid receptor agonist | |||
| 0.038 | 0.016 | 0.038 | HCV NS5B polymerase inhibitor | |||
| 0.127 | 0.105 | 0.129 | Protein-tyrosine phosphatase inhibitor | 0.129 0.102 CID_154699805 | CID_154699805 | |
| 0.136 | 0.114 | 0.151 | Interleukin 6 antagonist | 0.151 0.088 CID_154699805 | CID_154699805 | |
| 0.039 | 0.018 | 0.039 | Purinergic P2X3 antagonist | |||
| 0.072 | 0.051 | 0.072 | Glycine receptor agonist | |||
| 0.032 | 0.012 | 0.032 | Prostaglandin H2 antagonist | |||
| 0.11 | 0.092 | 0.11 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.055 | 0.038 | 0.055 | Dihydroorotate oxidase inhibitor | |||
| 0.044 | 0.027 | 0.044 | Guanylate cyclase inhibitor | 0.038 0.037 CID_154699805 | ||
| 0.101 | 0.085 | 0.101 | TRPA1 agonist | |||
| 0.123 | 0.107 | 0.268 | Thrombolytic | 0.268 0.03 CID_154699805 | CID_154699805 | |
| 0.026 | 0.011 | 0.026 | Bombesin agonist | |||
| 0.113 | 0.098 | 0.113 | Protein kinase (CK1) gamma inhibitor | |||
| 0.029 | 0.015 | 0.029 | Nicotinic acid receptor 2 antagonist | |||
| 0.024 | 0.01 | 0.024 | Lysophosphatidic acid 1 receptor antagonist | |||
| 0.023 | 0.009 | 0.023 | Retinoic acid beta receptor agonist | |||
| 0.04 | 0.026 | 0.04 | AMPA 4 receptor antagonist | |||
| 0.04 | 0.027 | 0.04 | Membrane dipeptidase inhibitor | |||
| 0.018 | 0.005 | 0.018 | Retinoic acid beta receptor antagonist | |||
| 0.022 | 0.009 | 0.022 | Bombesin 3 receptor agonist | |||
| 0.076 | 0.063 | 0.102 | Glycine receptor antagonist | 0.102 0.03 CID_154699805 | CID_154699805 | |
| 0.085 | 0.074 | 0.092 | Glutamate release inhibitor | 0.092 0.057 CID_154699805 | CID_154699805 | |
| 0.068 | 0.057 | 0.068 | Phospholipase D inhibitor | |||
| 0.147 | 0.136 | 0.147 | Focal adhesion kinase 2 inhibitor | |||
| 0.069 | 0.058 | 0.069 | Glutamate dehydrogenase inhibitor | |||
| 0.072 | 0.061 | 0.072 | GABA B receptor agonist | |||
| 0.019 | 0.009 | 0.019 | Prostaglandin EP4 agonist | |||
| 0.034 | 0.024 | 0.034 | RNA-directed RNA polymerase inhibitor | |||
| 0.023 | 0.013 | 0.023 | Alpha 2d adrenoreceptor agonist | |||
| 0.034 | 0.024 | 0.034 | Gonadotropin-releasing hormone receptor antagonist | |||
| 0.014 | 0.005 | 0.014 | Retinoic acid receptor gamma antagonist | |||
| 0.081 | 0.072 | 0.154 | NADH dehydrogenase inhibitor | 0.154 0.017 CID_154699805 | CID_154699805 | |
| 0.023 | 0.014 | 0.023 | Retinoic acid gamma receptor agonist | |||
| 0.1 | 0.092 | 0.1 | Caspase 3 inhibitor | |||
| 0.049 | 0.04 | 0.049 | Aconitate hydratase inhibitor | |||
| 0.038 | 0.03 | 0.038 | Retinoic acid alpha receptor agonist | |||
| 0.042 | 0.034 | 0.042 | Geranyltranstransferase inhibitor | |||
| 0.054 | 0.047 | 0.054 | Pregnane X receptor antagonist | |||
| 0.039 | 0.032 | 0.039 | Liver X receptor alpha agonist | |||
| 0.039 | 0.035 | 0.039 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.053 | 0.048 | 0.053 | Immunoglobulin Fc receptor antagonist | |||
| 0.041 | 0.037 | 0.041 | Glutamate (mGluR group III) antagonist | |||
| 0.044 | 0.041 | 0.052 | Glucose-6-phosphate isomerase inhibitor | 0.052 0.026 CID_154699805 | CID_154699805 | |
| 0.011 | 0.009 | 0.011 | Thrombopoietin agonist | |||
| 0.1 | 0.098 | 0.1 | Aldehyde dehydrogenase inhibitor | |||
| 0.084 | 0.082 | 0.084 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.026 | 0.024 | 0.026 | Glucagon receptor antagonist | |||
| 0.016 | 0.014 | 0.016 | Free fatty acid receptor 1 agonist | |||
| 0.019 | 0.018 | 0.019 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.031 | 0.032 | 0.039 | HMG CoA reductase inhibitor | 0.039 0.016 CID_154699805 | CID_154699805 | |
| 0.023 | 0.025 | 0.1 | Sodium/glucose cotransporter 2 inhibitor | 0.1 0.003 CID_154699805 | CID_154699805 | |
| 0.18 | 0.19 | 0.556 | Transcription factor NF kappa B inhibitor | 0.556 0.037 CID_154699805 | CID_154699805 | |
| 0.044 | 0.055 | 0.05 | Factor III inhibitor | 0.05 0.035 CID_154699805 | CID_154699805 | |
| 0.021 | 0.033 | 0.082 | Sodium/glucose cotransporter inhibitor | 0.082 0.003 CID_154699805 | CID_154699805 | |
| 0.052 | 0.066 | 0.097 | Phosphofructokinase-1 inhibitor | 0.097 0.033 CID_154699805 | CID_154699805 | |
| 0.076 | 0.092 | 0.104 | Uric acid excretion stimulant | 0.104 0.049 CID_154699805 | CID_154699805 | |
| 0.119 | 0.153 | 0.371 | Hepatoprotectant | 0.371 0.016 CID_154699805 | CID_154699805 | |
| 0.075 | 0.111 | 0.1 | Protein-tyrosine phosphatase 1B inhibitor | 0.1 0.078 CID_154699805 | CID_154699805 | |
| 0.047 | 0.088 | 0.065 | Lipocortins synthesis agonist | 0.065 0.028 CID_154699805 | CID_154699805 | |
| 0.172 | 0.22 | 0.274 | Caspase 3 stimulant | 0.274 0.094 CID_154699805 | CID_154699805 | |
| 0.064 | 0.126 | 0.199 | UDP-glucose 4-epimerase inhibitor | 0.199 0.018 CID_154699805 | CID_154699805 | |
| 0.066 | 0.132 | 0.186 | Topoisomerase II inhibitor | 0.186 0.036 CID_154699805 | CID_154699805 | |
| 0.174 | 0.24 | 0.429 | Interleukin 2 agonist | 0.429 0.02 CID_154699805 | CID_154699805 | |
| 0.08 | 0.149 | 0.208 | Cell adhesion inhibitor | 0.208 0.023 CID_154699805 | CID_154699805 | |
| 0.032 | 0.102 | 0.089 | Factor IXa inhibitor | 0.089 0.013 CID_154699805 | CID_154699805 | |
| 0.157 | 0.23 | 0.332 | Vasodilator, coronary | 0.332 0.065 CID_154699805 | CID_154699805 | |
| 0.134 | 0.209 | 0.471 | Hypoglycemic | 0.471 0.018 CID_154699805 | CID_154699805 | |
| 0.116 | 0.194 | 0.162 | Antiamyloidogenic | 0.162 0.132 CID_154699805 | CID_154699805 | |
| 0.038 | 0.122 | 0.078 | Na+ K+ transporting ATPase inhibitor | 0.078 0.052 CID_154699805 | CID_154699805 | |
| 0.051 | 0.147 | 0.097 | Mediator release inhibitor | 0.097 0.073 CID_154699805 | CID_154699805 | |
| 0.025 | 0.121 | 0.049 | Microtubule stabilization | 0.049 0.029 CID_154699805 | CID_154699805 | |
| 0.045 | 0.142 | 0.175 | Monophenol monooxygenase inhibitor | 0.175 0.039 CID_154699805 | CID_154699805 | |
| 0.027 | 0.127 | 0.054 | Alpha-mannosidase inhibitor | 0.054 0.036 CID_154699805 | CID_154699805 | |
| 0.08 | 0.185 | 0.166 | Anticoagulant | 0.166 0.068 CID_154699805 | CID_154699805 | |
| 0.029 | 0.142 | 0.071 | Heparanase inhibitor | 0.071 0.011 CID_154699805 | CID_154699805 | |
| 0.059 | 0.178 | 0.121 | AMP-activated protein kinase stimulant | 0.121 0.048 CID_154699805 | CID_154699805 | |
| 0.009 | 0.129 | 0.019 | Antibiotic Anthracycline-like | 0.019 0.014 CID_154699805 | CID_154699805 | |
| 0.017 | 0.149 | 0.041 | Mannosidase inhibitor | 0.041 0.038 CID_154699805 | CID_154699805 | |
| 0.093 | 0.234 | 0.409 | Immunostimulant | 0.409 0.047 CID_154699805 | CID_154699805 | |
| 0.053 | 0.203 | 0.178 | Beta glucuronidase inhibitor | 0.178 0.016 CID_154699805 | CID_154699805 | |
| 0.061 | 0.215 | 0.134 | Cyclooxygenase 3 inhibitor | 0.134 0.063 CID_154699805 | CID_154699805 | |
| 0.043 | 0.213 | 0.107 | Cell adhesion molecule inhibitor | 0.107 0.03 CID_154699805 | CID_154699805 | |
| 0.113 | 0.294 | 0.216 | DNA synthesis inhibitor | 0.216 0.1 CID_154699805 | CID_154699805 | |
| 0.019 | 0.204 | 0.316 | Selectin antagonist | 0.316 0.005 CID_154699805 | CID_154699805 | |
| 0.048 | 0.236 | 0.235 | Lipid peroxidase inhibitor | 0.235 0.03 CID_154699805 | CID_154699805 | |
| 0.092 | 0.28 | 0.14 | ATPase inhibitor | 0.14 0.121 CID_154699805 | CID_154699805 | |
| 0.076 | 0.265 | 0.163 | Insulin secretagoues | 0.163 0.062 CID_154699805 | CID_154699805 | |
| 0.115 | 0.308 | 0.616 | Alpha-glucosidase inhibitor | 0.616 0.05 CID_154699805 | CID_154699805 | |
| 0.057 | 0.251 | 0.542 | Angiogenesis stimulant | 0.542 0.01 CID_154699805 | CID_154699805 | |
| 0.087 | 0.283 | 0.482 | Antioxidant | 0.482 0.022 CID_154699805 | CID_154699805 | |
| 0.072 | 0.272 | 0.328 | Nitric oxide antagonist | 0.328 0.035 CID_154699805 | CID_154699805 | |
| 0.043 | 0.259 | 0.122 | Amylase inhibitor | 0.122 0.08 CID_154699805 | CID_154699805 | |
| 0.069 | 0.288 | 0.319 | Platelet adhesion inhibitor | 0.319 0.028 CID_154699805 | CID_154699805 | |
| 0.164 | 0.384 | 0.295 | Caspase 9 stimulant | 0.295 0.199 CID_154699805 | CID_154699805 | |
| 0.037 | 0.27 | 0.109 | Alkylator | 0.109 0.079 CID_154699805 | CID_154699805 | |
| 0.033 | 0.276 | 0.108 | Bronchodilator | 0.108 0.055 CID_154699805 | CID_154699805 | |
| 0.022 | 0.269 | 0.091 | Topoisomerase II alpha inhibitor | 0.091 0.045 CID_154699805 | CID_154699805 | |
| 0.061 | 0.309 | 0.181 | Interleukin agonist | 0.181 0.138 CID_154699805 | CID_154699805 | |
| 0.044 | 0.3 | 0.115 | Transcription factor NF kappa B stimulant | 0.115 0.028 CID_154699805 | CID_154699805 | |
| 0.115 | 0.374 | 0.332 | Apoptosis antagonist | 0.332 0.065 CID_154699805 | CID_154699805 | |
| 0.042 | 0.311 | 0.119 | Interleukin 5 antagonist | 0.119 0.024 CID_154699805 | CID_154699805 | |
| 0.058 | 0.329 | 0.163 | Spasmolytic | 0.163 0.152 CID_154699805 | CID_154699805 | |
| 0.059 | 0.339 | 0.406 | Free radical scavenger | 0.406 0.028 CID_154699805 | CID_154699805 | |
| 0.103 | 0.403 | 0.324 | Peptidyltransferase inhibitor | 0.324 0.017 CID_154699805 | CID_154699805 | |
| 0.014 | 0.332 | 0.06 | Neuraminidase (influenza) inhibitor | 0.06 0.053 CID_154699805 | CID_154699805 | |
| 0.057 | 0.375 | 0.153 | Hemostatic | 0.153 0.064 CID_154699805 | CID_154699805 | |
| 0.034 | 0.377 | 0.104 | DNA polymerase I inhibitor | 0.104 0.082 CID_154699805 | CID_154699805 | |
| 0.033 | 0.412 | 0.142 | Toll-Like receptor 4 antagonist | 0.142 0.026 CID_154699805 | CID_154699805 | |
| 0.005 | 0.4 | 0.115 | Antineoplastic antibiotic | 0.115 0.04 CID_154699805 | CID_154699805 | |
| 0.016 | 0.445 | 0.147 | Topoisomerase I inhibitor | 0.147 0.042 CID_154699805 | CID_154699805 | |
| 0.01 | 0.482 | 0.077 | Protein 50S ribosomal subunit inhibitor | 0.077 0.021 CID_154699805 | CID_154699805 | |
| 0.052 | 0.568 | 0.302 | Immunomodulator | 0.302 0.081 CID_154699805 | CID_154699805 | |
| 0.01 | 0.543 | 0.027 | Toll-Like receptor 4 agonist | 0.027 0.018 CID_154699805 | CID_154699805 | |
| 0.017 | 0.566 | 0.106 | Multidrug resistance-associated protein 1 inhibitor | 0.106 0.068 CID_154699805 | CID_154699805 | |
| 0.028 | 0.585 | 0.31 | Tumour necrosis factor alpha release inhibitor | 0.31 0.049 CID_154699805 | CID_154699805 | |
| 0.021 | 0.61 | 0.209 | Vasodilator | 0.209 0.097 CID_154699805 | CID_154699805 | |
| 0.01 | 0.644 | 0.058 | Antibiotic Aminoglycoside-like | 0.058 0.009 CID_154699805 | CID_154699805 | |
| 0.041 | 0.682 | 0.485 | Apoptosis agonist | 0.485 0.079 CID_154699805 | CID_154699805 | |
| 0.004 | 0.66 | 0.025 | Protein 30S ribosomal subunit inhibitor | 0.025 0.016 CID_154699805 | CID_154699805 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |